Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation

INTRODUCTION: Until recently, patients discontinuing first-line (1L) hedgehog inhibitors (HHIs) for basal cell carcinoma (BCC) had few subsequent treatment options. The objective of this study was to describe the treatment journey and prognosis of patients discontinuing 1L HHI for BCC. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowey, Lance, Chen, Chieh-I., Aguilar, Kathleen M., Davies, Kalatu, LaFontaine, Patrick R., Fury, Matthew G., Bowler, Timothy, Golozar, Asieh, Jalbert, Jessica J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110576/
https://www.ncbi.nlm.nih.gov/pubmed/35507216
http://dx.doi.org/10.1007/s13555-022-00724-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110576/
https://www.ncbi.nlm.nih.gov/pubmed/35507216
http://dx.doi.org/10.1007/s13555-022-00724-y

Ejemplares similares